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 ABSTRACT
Tubulointersticial nephritis and uveitis syndrome is an idiopathic and rare cause of acute kidney injury that 
should not overlooked, because it usually requires specific therapeutic interventions. 
We report two distinct cases: a young and an elder female. Both cases presented with unspecific constitutional 
symptoms but had different onset of renal and ocular involvement. Both were treated with topical and systemic 
corticoids and although there was a good initial response in both cases, an early relapse after steroids taper was 
observed in the younger patient and a persistent renal dysfunction in the older one.
A high clinical suspicion and understanding of this disease is necessary for an adequate management and 
treatment of these patients. Recent data associates a worse renal prognosis when the disease appears in 
advanced age. In both of our cases the outcome was good but we had a short follow-up. The histological 
presentation of this disease in our older patient was similar to that reported in the literature, with a high 
percentage of fibrosis and chronicity of renal tissue that can contribute to the higher grade of renal dysfunc-
tion in this type of patients.
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 INTRODUCTION
Tubulointersticial nephritis and uveitis (TINU) syn-
drome is defined by the combination of both idiopathic 
acute tubulointersticial nephritis (AIN) and uveitis. 
It was described for the first time in 1975 by Dobrin 
et al.1 and more than 250 cases have now been report-
ed, mostly in children and young females2,3, although 
it has also been reported in adults. There is also a 
female predominance in all series3,4. Estimated preva-
lence is around 3.5 cases/million of persons and the 
incidence is 0.2 cases/million/year5,6.
No identifiable risk factors have been found in at 
least 50 percent of cases3,4. In some of them, prior 
infections and/or use of specific drugs have been 
reported3,4,7. There is no particular affinity with race, 
familiar inheritance, genetics or geographic clusters3.
The correct diagnosis can be difficult to establish 
especially when the renal involvement is mild. The 
exclusion of other systemic diseases is mandatory and 
the ophthalmological evaluation plays an important 
role in the presence of interstitial nephritis with no 
defined etiology.
We report two different cases of TINU syndrome, 
one in a young and another in an older female. Although 
they had similar constitutional symptoms at presenta-
tion, the renal and ocular manifestations as well as the 
response to the treatment was distinct. 
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 CASES REPORT
 Case 1
An 18-year-old female with recent diagnosis of 
hyperthyroidism presented in the emergency depart-
ment with a 9 months’ history of photophobia. She 
was treated with antibiotics, given the suspicion of 
bilateral purulent conjunctivitis. Two months before 
admission started, there were complaints of weight 
loss, vomiting, abdominal pain, diarrhea, fatigue and 
anorexia. Blood samples showed anemia and altered 
renal function with serum creatinine (sCr) of 1.8mg/
dL, hypouricemia and hypophosphatemia. Presence of 
glycosuria, granular casts and proteinuria (< 1g/per day) 
was visible in the urinalysis. Renal ultrasonography was 
normal as were immunological markers (antinuclear 
antibody (ANA), antineutrophil cytoplasmic antibody 
(ANCA), anti-double-stranded DNA (anti-dsDNA), HLA-
B27, anti-RNP/Smith, SSA, SSB, SCL70, and antoJo1). 
Angiotensin converting enzyme (ECA) and serology for 
syphilis (VDRL) were also negative. Kidney biopsy 
revealed mesangial expansion without mesangial 
hyper-cellularity and thickening of Bowman´s capsule. 
Extensive interstitial inflammation with lymphoplas-
mocytic predominance occupying more than 25% of 
the extension of the cortex was observed. Fibrosis in 
approximately 5 to 10% of the cortical extension was 
noticeable. Tubular atrophy was present in 10% of the 
cortex. Arterial branches and arterioles had concentric 
wall thickening. The direct immunofluorescence study 
with antibodies to albumin, C3, C4, C1q, IgA, IgG and 
IgM showed vestigial mesangial and focal C3 in the 
tubular membrane with absence of deposits for the 
remaining antibodies tested. Electron microscopy 
showed no ultrastructural changes.
Ophthalmologic evaluation documented bilateral 
anterior uveitis. She started corticoid therapy, ocular 
and systemic (prednisolone 1mg/Kg/day), with early 
recovery of renal function. She had recurrent uveitis 
when steroids taper was performed (after 3 months), 
with 2 episodes of recurrent uveitis, the last one need-
ing systemic corticotherapy (completing 1 year of pred-
nisolone). After 2 years, she maintains normal renal 
function (sCr of 1mg/dL) and no signs of tubular dys-
function (ratio proteinurine/creatinineurine 0.1g/g), no 
glycosuria (0mg/dL) or granular casts (0-2/field).
 Case 2
A 71-year-old female with an unremarkable past 
medical history: no chronic medication or recent use 
of nonsteroidal anti-inflammatory drugs (AINEs); no 
history of tobacco or alcohol. She presented with 
weight loss, fatigue, asthenia and malaise in the previ-
ous 4 months. No other symptoms were reported. At 
Filipa Silva, Sofia O Correia, Ana Castro, Carla Moreira, Sofia Santos, Jorge Malheiro, Josefina Santos, La Salete Martins, António Cabrita
Figure 1
Renal histology of case 1 on hematoxilin eosin – Intense inflamatory with linfocits predominance, focal lesions of neutrofilic tubulite and atrophy in 30-40%. 
Fibrosis in 30-40%. Preserved blood vessels.
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hospital admission she presented with an elevated 
C-reactive protein (CRP), 100mg/L and erythrocyte 
sedimentation rate (ESR), 74mm. Blood samples 
showed new onset of normocytic, normochromic ane-
mia (haemoglobin 9.3g/dL) and acute renal failure 
KDIGO 3 (sCr increased from 0.9mg/dL to 3.1mg/dL). 
Urinalysis showed proteinuria (ratio proteinurine/cre-
atinineurine 1.2g/g), glycosuria (>1000mg/dL) and 
granular casts (10-25/field) and no eosinophiluria or 
eosinophilia. No abnormalities in the renal ultrasound 
were observed. ANA, ANCA, anti-dsDNA, HLA-B27, anti-
RNP/Smith, SSA, SSB, SCL70, and antoJo1 antibodies 
were negative. ECA and VDRL were also negative. In 
renal biopsy, two of the twenty-six glomeruli identified 
had global sclerosis, showing interstitial inflammation 
with intense infiltrate of lymphocyte predominance, 
occupying 25% of cortical extension. Fibrosis in 30 to 
40% of the sample was noticeable. Renal tubules 
appeared with thickened basement membrane and 
focal lesions of neutrophilic tubulitis. Tubular atrophy 
in 30 to 40% was detectable. Arterial branches and 
arterioles had discrete intima myofibroblastic thicken-
ing. Immunofluorescence study with antibodies to 
albumin, C3, C4, C1q, IgA, IgG, IgM, kappa and lambda 
chains revealed absence of immune deposits. Immu-
nohistochemical study was compatible with lymphocyte 
population composed mainly by T lymphocytes. She 
had no ocular symptoms but evidence of bilateral ante-
rior uveitis was present on ocular examination. Pred-
nisolone, 1mg/Kg/day, was initiated with early recover 
of renal function. She started steroids taper after 3 
months and they were stopped after 5 months (sCr 
1.4mg/dL). After 10 months of follow-up she had no 
anemia (Hb 12.9g/dL), low VS (10mm), sCr 1.4mg/dL 
and no signs of tubular dysfunction (ratio proteinurine/
creatinineurine 0.3g/g), no glycosuria (0mg/dL) or granu-
lar casts (0-2/field). 
 DISCUSSION
With this case report the authors want to emphasize 
the importance of suspecting this syndrome when in 
the presence of an acute interstitial nephritis of unclear 
etiology. In addition, idiopathic AIN patients must have 
an ocular examination since they could have uveitis 
with no ocular symptom, as was the case in one of the 
patients.
It is also important to notice that despite the lack 
of long-term follow-up, the older patient appears to 
have a worse prognosis and the difference could in part 
be explained by the tendency for accelerated fibrosis 
in the older patient.
The underlying mechanism of TINU remains unclear. 
Some studies suggest that IgG antibodies directed to 
modified CRP, an autoantigen common to both renal 
tubular cells and uvea may be implicated in the patho-
genesis, since they are significantly higher in TINU 
patients than when compared with patients with other 
diseases (Sjogren syndrome, drug-induced interstitial 
nephritis, glomerulonephritis, IgA nephropathy, mini-
mal change disease, ANCA associated vasculitis and 
amyloidosis) or healthy controls8.
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Figure 2
Renal histology of case 2 on periodic acid-Schiff (A) ans hematoxilin eosin (B) – mesangial expansion without mesangial hyper-cellularity and thickening 
of Bowman’s capsule. Extensive inflammatory infiltrate of lymphoplasmocytic predominance.
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Gafter at al.9 associated TINU syndrome to the sup-
pression of cell-mediated immunity and reported normal 
T-cell population but decreased secretion of lymphokines 
and anergy to skin tests in these patients. This paradox 
is not unique to TINU, as increased tissue inflammation 
with concomitant suppression of peripheral immunity 
is also seen in patients with sarcoidosis9,10.
Other studies reported a genetic association with 
HLA-DQA1*01, HLADQB1*05 and HLA-DQB1*013,7.
There has also been reported TINU syndrome in 
patients with autoimmune diseases like hypoparathy-
roidism, thyroid disease, immunoglobulin G4 related 
autoimmune disease and rheumatoid arthritis3,8,11-13.
TINU may present with unspecific general symp-
toms4,14 like those that occurred in both of our patients.
The typical ocular presentation of TINU syndrome 
is bilateral and nongranulomatous anterior uveitis with 
sudden onset in 80% of patients, but may also manifest 
as posterior or panuveitis4,16. Ocular symptoms include 
eye redness and pain, photophobia and decreased 
visual acuity.
Renal manifestations include flank pain, sterile pyu-
ria, proteinuria, hematuria and acute kidney injury. 
Proximal and distal tubular defects can be commonly 
seen, resulting in aminoaciduria, glycosuria, phospha-
turia and acidifications defects17,18. Nephritis precedes 
uveitis in 65%, in 21% of cases uveitis is present before 
nephritis and in 15% the two occur in simultaneously4. 
In our report, one patient presented first ocular disease 
and the other renal involvement.
There are no specific serum markers or laboratory 
findings that suggest TINU. We may find leucocy-
turia, eosinophilia, anemia, slightly abnormal liver 
functions test and an elevated ESR and CRP3. Beta 
2 microglobulin and Krebs von den Lunge-6 (KL-6) 
could be two potential diagnostic markers according 
to some reports and the levels of beta 2 microglobu-
lin were correlated with histologic grade of tubu-
lointerstitial nephritis in 10 children19. Compared 
with patients with uveitis from other causes, serum 
KL-6 levels were significantly elevated in patients 
with TINU syndrome. Renal biopsies stained strongly 
with anti KL-6 antibody suggest that the elevated 
KL-6 levels reflect the underlying renal lesion20. 
However, KL-6 levels were no different between 
patients with TINU syndrome or drug-induced inter-
stitial nephritis3.
TINU syndrome might be underdiagnosed due to 
lack of recognition8. The definitive diagnosis is non-
specific and is suggested by the combination of renal 
involvement and uveitis with renal biopsy consistent 
with AIN. On light microscopy, typical biopsy findings 
include tubulointerstitial edema and infiltration of 
inflammatory cells composed mainly of mononuclear 
cells. Glomerular and vascular structures are generally 
preserved. There are no specific findings with immu-
nofluorescence and electron microscopy21.
In our cases, all kidneys biopsies had inflammatory 
infiltrate with lymphocyte predominance. No altera-
tions on immunofluorescence or electronic microscopy 
were found. The older patient presented with more 
fibrosis and tubular atrophy translating into a worse 
outcome when compared with the younger patient, 
who had less signs of chronicity on biopsy.
Treatment is not yet standardized and varies between 
centers and clinicians22.
Topical corticosteroids are recommended as the first-
choice treatment in anterior uveitis24. However, 80% 
of patients requires systemic corticosteroids and 9% 
progress to other immunosuppressive treatment4. 
Sobolewska et al.23 suggested that treatment duration 
of at least 12 months with oral systemic corticosteroids 
or immunomodulatory agents may reduce or prevent 
the recurrence rate in patients who relapse.
Our approach consists in initiate both topic and sys-
temic corticoterapy. We usually initiate, as is recom-
mended20, with oral prednisolone at 1mg/kg/day in 
cases with progressive renal impairment. Therapy is 
given by three to six months depending on the response 
and then is slowly tapered. In our cases we started 
tapering corticoterapy after 3 months and stopped after 
5. The younger patient had a relapse of uveitis after 
systemic corticoterapy tapering, with accordance with 
literature that report more tendency for eye symptoms 
than renal to occur (40% vs 9%, respectively, at 1 year 
follow up)3,4,22,24. On the other hand, the older patient 
progressed to chronic disease, which is more frequent 
for renal symptoms. None of them has of yet started 
any additional immunosuppressive drugs.
The long term prognosis isn’t well established since 
there is few data to follow-up along with. While the most 
reports described TINU syndrome as having a favorable 
renal outcome4,19,24,25, other data suggests that full 
renal recovery is not the norm, with the patients evolving 
to impaired renal function in the medium term3,22.
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Legendre et al22. recently report new data suggesting 
that with the older the patient is, the poorer is the 
renal prognosis after 1 year of follow-up. In addition, 
they also associated the initial severity of renal symp-
toms with the renal function after 1 year of follow-up. 
This data was in accordance with our cases, in which 
the older patient presented with a higher grade of renal 
dysfunction, more fibrosis was present in the renal 
biopsy and there was a progression to chronic renal 
dysfunction.
Until now, no pathological markers proved to be 
prognostic factors in TINU syndrome3,4.
 CONCLUSION
TINU syndrome is a rare disease and it may be dif-
ficult to identify.
Patients that have acute interstitial nephritis on renal 
biopsy and have no obvious underlying cause may 
require a slit lamp examination to exclude uveitis.
This disease should be considered in the differential 
diagnosis of tubulointersticial nephritis of unclear etiol-
ogy, especially in the presence of ocular manifestations, 
in older patients where the disease is probably under-
diagnosed, and in young patients with asymptomatic 
mild renal disease.
The long-term care is fundamental given the possible 
evolution with impaired renal function, especially in 
elder people.
Disclosure of potential conflicts of interest: the authors declare no 
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